md phd unicamp

Programa de Pesquisador em Medicina

Deliberação consu-a-008/2012, de 29/05/2012  -  cria o programa pesquisador em medicina que permite que alunos de graduação do curso de medicina da unicamp se matriculem em disciplinas de programas de pós-graduação stricto sensu da universidade estadual de campinas., processo seletivo 2024  , comissão do programa de pesquisador em medicina.

Coordenador: Prof. Dr. José Guilherme Cecatti

Prof. Dr. Marcondes Cavalcante França Junior Prof. Dr. Roger Frigério Castilho Prof. Dr. Fábio Hüsemann Menezes Prof. Dr.  Erich Vinicius de Paula Dra. Silvia Maria Riceto Ronchim Passeri

Secretário: Yuri G.V. Ferreira de Lima

• 7563 visualizações

Fique de Olho!

Fique de Olho

• Processo Seletivo

Comissão de Pós-Graduação da Faculdade de Ciências Médicas

Endereço:  Rua Tessália Vieira de Camargo, n.º 126, FCM-06 – "Cidade Universitária Zeferino Vaz" – Campinas / SP, Brasil – CEP: 13083-887   Telefones:  

+55 (19) 3521-8862  

+55 (19) 3521-8919

+55 (19) 3521-8861    Horário de atendimento:   segunda a sexta-feira, das 08h30 às 17h

Palavras-chave

• 2º Semestre 2023
• ingresso; mestrado; doutorado
• processo seletivo

Faculdade de Ciências Médicas Universidade Estadual de Campinas

Correspondência: Rua Vital Brasil, 80. Cidade Universitária Zeferino Vaz. CEP 13083-888 – Campinas, SP, Brasil Acesso: R. Albert Sabin, s/ nº. Cidade Universitária "Zeferino Vaz" CEP: 13083-894. Campinas, SP, Brasil.

Assine nossa newsletter Auditório Aulas e eventos Notícias Transmissão ao vivo

Colegiados cipa setorial administração videoconferência.

Copyright © 2024. Todos os direitos reservados. Desenvolvido por Núcleo de Tecnologia da Informação - FCM

What Are You Looking For?

Popular tags.

• Intermediate
• Interactive Webinar

Margareth C. Ozelo, MD, PhD University of Campinas Hemocentro UNICAMP, Brazil Campinas, São Paulo, Brazil

Dr. Margareth C. Ozelo is Associate Professor of Internal Medicine Department, and Director of the Haematology Division from University of Campinas (UNICAMP) in Campinas, São Paulo, Brazil. She received her medical degree (1994), specialist training in haematology and transfusion medicine (1994-1997), and PhD (2004) at UNICAMP before undertaking a postdoctoral fellowship in David Lillicrap’s laboratory, at Queen’s University in Kingston, Ontario, Canada, focused in gene therapy for haemophilia (2006–2009).

Dr. Ozelo is also the Director of the WFH International Haemophilia Training Centre (IHTC) from Hemocentro UNICAMP. In 2012, she was nominated as a member of the Novo Nordisk Haemophilia Foundation Council and was member of the Executive Committee of the World Federation of Haemophilia from 2012 to 2014.

Dr Ozelo is involved with several research projects, including, gene therapy for haemophilia, risk factors for inhibitor development, immune tolerance induction, and the management of musculoskeletal complications of haemophilia, and inherited platelet disorders.

Please enable the javascript to submit this form

• Term of Use
• Privacy Policy

Supported by educational grants from BioMarin, CSL Behring, Pfizer and Spark Therapeutics

Processo Seletivo – Mestrado e Doutorado

A Comissão de Pós-Graduação da Faculdade de Engenharia Química da Universidade Estadual de Campinas torna público o Edital de abertura de inscrições e estabelece as normas para o processo seletivo. A documentação deve ser enviada por e-mail para secretaria do programa.

Para saber mais, clique aqui

Disciplinas e Horário Pós Graduação

As disciplinas e horários para o primeiro semestre de 2024 já estão disponíveis. Fique atento para a seleção das disciplinas de acordo com o seu curso de pós-graduação (mestrado ou doutorado) e os critérios exigidos para titulação.

Disciplinas 1º semestre de 2024

Horários e Distribuição das Salas das Disciplinas – 1º semestre de 2024

Programa das Disciplinas Obrigatórias

Programa das Disciplinas Eletivas do 1º Semestre de 2024

Graduate Seminar Series

O Graduate Seminar Series é um fórum de seminários que é realizado totalmente em língua inglesa. Os seminários são disponibilizados no nosso canal do YouTube:

https://www.youtube.com/c/PPGFEQ/featured

Dr Fatemeh Salehi is the Academic Lead for Sustainability at the Faculty of Science and Engineering and an Associate Professor at the School of Engineering, Macquarie University. Her expertise is in the development of physical models for computational fluid dynamic simulations of single- and multi-phase flows to advance sustainable energy technologies. Her team is particularly interested in computational modelling and optimisation techniques to scale the safe and efficient applications of clean fuels such as hydrogen, ammonia, and biomass. Her research in the field of hydrogen application has been recognised in the NSW Hydrogen Strategy published by the NSW Government, Australia in 2021. Dr Salehi is a Fulbright alumni, an International Hydrogen Fellow, an executive member of the Combustion Institute, a member of the Scientific Advisory Board of Blue Economy Corporative Research Centre, and a member of Working Groups of Standards Australia for the development of hydrogen standards. She is also a recipient of the NSW Young Tall Poppy Award, the Maria Skyllas-Kazacos Early Career Award, the Australasian Fluid Mechanics Society Emerging Leaders Award, and the Bilger Early Career Researcher Award.

Seminar: “Hydrogen: challenges and opportunities – an Australian perspective”

Abstract:  Hydrogen is a potential energy solution to address global warming, climate change, and energy security challenges. It can create a practical pathway to replace fossil fuels and move toward net-zero targets in the transport, heavy industries, and energy sectors. Various hydrogen strategies and industry roadmaps have been developed to identify key goals, set targets for progress, and develop strategic plans to address challenges such as high costs associated with production, storage, operation, and maintenance systems, as well as concerns about safety, reliability, and regulatory approvals. This talk provides an overview of hydrogen challenges and opportunities from an Australian perspective and discusses some key safety concerns in scaling hydrogen.

10th of  May 2024. 09:00 hs. On YouTube.  https://www.youtube.com/@PPGFEQ

Abbas Firoozabadi has a PhD degree from the Illinois Institute Technology and did post-doctoral research at the University of Michigan, Ann Arbor, MI. Professor Firoozabadi has taught graduate level courses on equilibrium and irreversible thermodynamics at the University of Texas-Austin, Imperial College London, Yale University, Tokyo University, Rice University, and Peking University. He has established a research consortium at the Reservoir Engineering Research Institute (RERI) in Palo Alto, Ca with the funding from major energy companies in the US and abroad, and US-DOE.

Seminar: “CO2 Viscosification for Improvement in Safety and Efficiency of Aquifer Sequestration, CO2-Improved Oil Recovery and other Broad Applications”

22th of February 2024. 14:00 hs. FEQ´s Defense Room. Building D

Leibniz Institute for Materials Engineering-IWT, Badgasteiner Str. 3, 28359 Bremen, Germany

The Prof. Udo Fritsching carries out academic research at the Department of Process Engineering at the Leibniz Institute for Materials Engineering (IWT), the Centre for Materials and Processes and he is a professor at the University of Bremen, Germany.

Seminar: “Emulsification of bio-active ingredients – from molecular to process level”

30th of November 2023 10:00 hs FEQ´s Main Hall Building D

FAPERJ Visiting Professor The Federal University of Rio de Janeiro – Rio de Janeiro, Brazil Director of 3D Bioprinting Center – The Moscow University of Physics and Engineering (The Nuclear University), Moscow, Russia Leading scientist – Regenerative Medicine Institute Sechenov Moscow Medical University, Moscow, Russia

Seminar: “Organ printing: from idea to clinical translation”

24th of August 2023. 09:00 hs.  FEQ´s Main Hall. Building D

School of Chemical Engineering Universidad San Buenaventura https://usbcartagena.edu.co/

Seminar “Hazards in delayed coking units”

25th of August 2023. 13:00 hs. – YouTube @PPGFEQ

Bem vindo à página do PPG-FEQ

O Programa de Pós-Graduação em Engenharia Química da Universidade Estadual de Campinas (UNICAMP) tem por finalidade habilitar, em suas diversas áreas de concentração, profissionais de nível superior para desenvolver atividades ligadas à pesquisa, docência e desenvolvimento científico e tecnológico no campo da Engenharia Química. O Curso de Pós-Graduação foi iniciado em março de 1980 no nível de Mestrado e em março de 1989 no nível de Doutorado. As atividades de ensino e pesquisa estão concentradas na Área de Concentração em Engenharia Química, e são desenvolvidas no âmbito dos departamentos:

Departamento de Desenvolvimento de Processos e Produtos (DDPP)

Departamento de engenharia de materiais e bioprocessos (dembio), departamento de engenharia de processos (depro), departamento de engenharia de sistemas químicos (desq).

After you have typed in some text, hit ENTER to start searching...

WassUp 1.9.4.5 timestamp: 2024-06-01 05:27:15AM UTC (02:27AM) Se a data acima não for a atual, esta página é de arquivo.

• Sobre o PPG
• Coordenação
• Linhas de Pesquisa
• Laboratórios
• Bibliotecas
• Proficiência em Língua Estrangeira
• Orientação de Tese e Dissertação
• Bolsa de Estudo
• Disciplinas
• Manual para os Ingressantes
• Acesso às Instalações
• Publicações Científicas
• Conduta na Pesquisa
• Patrimônio Genético – PATGEN
• Programa de Estágio Docente
• Intercâmbio Internacional
• Defesa de Dissertação e Tese
• Seminário e Exame de Qualificação
• Defesas Agendadas
• Prorrogar prazo de divulgação de tese/dissertação
• Desvinculação do Programa
• Outras Normas
• Formulários
• Processos Seletivos
• Resultado & Matrícula
• Lectio et scientia
• Projeto Dianoia

• skip to Cookie Notice
• skip to Main Navigation
• skip to Main Content
• skip to Footer
• Find a Doctor
• Find a Location
• Appointments & Referrals
• Patient Gateway
• Español
• Leadership Team
• Quality & Safety
• Equity & Inclusion
• Community Health
• Education & Training
• Centers & Departments
• Browse Treatments
• Browse Conditions A-Z
• View All Centers & Departments
• Clinical Trials
• Cancer Clinical Trials
• Cancer Center
• Digestive Healthcare Center
• Heart Center
• Mass General for Children
• Neuroscience
• Orthopaedic Surgery
• Information for Visitors
• Maps & Directions
• Parking & Shuttles
• Services & Amenities
• Accessibility
• Visiting Boston
• International Patients
• Medical Records
• Billing, Insurance & Financial Assistance
• Privacy & Security
• Patient Experience
• Explore Our Laboratories
• Industry Collaborations
• Research & Innovation News
• About the Research Institute
• Innovation Programs
• Education & Community Outreach
• Support Our Research
• Find a Researcher
• News & Events
• Ways to Give
• Patient Rights & Advocacy
• Website Terms of Use
• Apollo (Intranet)

Barbara Voetsch, MD, PhD

• Like us on Facebook
• Follow us on Twitter
• See us on LinkedIn
• Print this page

Not Accepting New Patients

Contact Information

Boston, MA Phone: 855-644-6387

Waltham, MA Phone: 617-726-8459

View Location Details

About Barbara Voetsch, MD, PhD

Departments, Centers, & Programs:

Clinical Interests:

• Carotid disease
• Cerebrovascular disease
• Cervical artery dissections
• Ischemic Stroke
• Stroke in young adults
• Stroke Prevention
• Venous sinus thrombosis
• German, Portuguese

Mass General Neurology 55 Fruit St. Boston , MA   02114 Phone: 855-644-6387

Mass General Neurology at Waltham 52 Second Ave. Suite 3100 Waltham , MA   02451 Phone: 617-726-8459

Medical Education

• MD, State University of Campinas (UNICAMP) / Faculdade de Ci?ncias M?dicas
• Residency, Massachusetts General Hospital
• Residency, State University of Campinas (UNICAMP) / Faculdade de Ci?ncias M?dicas
• Fellowship, Boston Medical Center
• Fellowship, State University of Campinas (UNICAMP) / Faculdade de Ci?ncias M?dicas

American Board Certifications

• Neurology, American Board of Psychiatry and Neurology
• Vascular Neurology, American Board of Psychiatry and Neurology

Accepted Insurance Plans

• Beech Street
• Blue Cross Blue Shield
• Blue Cross Blue Shield Medicare
• Commonwealth Care Alliance
• Fallon Health
• Harvard Pilgrim Health Care
• Maine Community Health Options
• Mass General Brigham Health Plan
• Medicaid ME
• Medicaid NH
• Medicaid RI
• Medicaid VT
• Medicare ACO
• Railroad Medicare
• Senior Whole Health
• Tufts Health Plan
• United Health Care
• WellSense NH

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Reviews: Comments and Ratings

#1 research hospital in america.

Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2023-2024.

• Search Menu
• Sign in through your institution
• Advance articles
• COVID-19 articles
• Editor's Choice
• CME/SAM Articles
• Author Guidelines
• Open Access
• Submission Site
• Why publish?
• Advertising and Corporate Services
• Advertising
• Reprints and ePrints
• Sponsored Supplements
• Branded Books
• About American Journal of Clinical Pathology
• About the American Society for Clinical Pathology
• Editorial Board
• Self-Archiving Policy
• Journals on Oxford Academic
• Books on Oxford Academic

Article Contents

• < Previous

Immunohistochemical Study of M1 and M2 Macrophages Population in Chronic Villitis of the Placenta

• Article contents
• Figures & tables
• Supplementary Data

Erika Egal, Natalia de Magalhães Rodrigues, Fernanda Mariano, Reydson Souza, Joao Scarini, Welligton Sabino, Leisa Aguiar, Victor Montalli, Rogerio Gondak, Ciro Soares, Thayná Morais, Albina Altemani, Immunohistochemical Study of M1 and M2 Macrophages Population in Chronic Villitis of the Placenta, American Journal of Clinical Pathology , Volume 152, Issue Supplement_1, October 2019, Page S102, https://doi.org/10.1093/ajcp/aqz120.001

• Permissions Icon Permissions

Villitis is characterized by the presence of inflammatory infiltrate (CD8 lymphocyte) in the placental villous and is classified as to the etiology in known and unknown. In most cases, villitis is idiopathic (villitis of unknown etiology [VUE]) because no microorganisms are evident and there are no maternal symptoms or signs. It has recently been proposed that pregnancy is, in fact, an active and highly regulated immune process in which macrophages play an important role. Macrophages may present with M1 phenotype, important effector cells, or M2 phenotype, capable of suppressing the function of M1 macrophages and influencing immunoregulation and tissue repair. CD68 antibody recognizes macrophages M1 and M2, whereas CD11c and CD163 antibodies are specific for the identification only of M1 and M2 macrophages, respectively. The objective of our study is to characterize in human placentas in the subpopulation of M1 and M2 macrophages in VUE.

Sixteen cases of chronic villitis (all without an identifiable etiologic agent) and three control placentas were examined using immunohistochemistry with antibodies for CD68, CD11c, CD163, and CD3.

CD68 and CD163 were present in all cases in the normal areas. CD68, CD163, and CD11c were present in the villous stroma and in the intervillous space in the inflamed areas. The percentage of CD68-positive macrophages was higher than CD163- and CD11c-positive macrophages in all specimens studied. A total increase of CD68, CD163, and CD11c with the predominance of CD11c over CD163 in the inflamed areas was observed.

The predominance of M1 macrophages (CD11c) in the inflamed areas suggests the influence of these cells in the pathogenesis VUE. The higher amount of M2 (CD163) in the inflamed villous compared to normal areas suggests a possible immunoregulatory mechanism of the inflammatory process in VUE.

Email alerts

Citing articles via.

• Recommend to your Library

Affiliations

• Online ISSN 1943-7722
• Print ISSN 0002-9173
• Copyright © 2024 American Society for Clinical Pathology
• About Oxford Academic
• Publish journals with us
• University press partners
• What we publish
• New features  
• Open access
• Institutional account management
• Rights and permissions
• Get help with access
• Accessibility
• Media enquiries
• Oxford University Press
• Oxford Languages
• University of Oxford

Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide

• Copyright © 2024 Oxford University Press
• Cookie settings
• Cookie policy
• Privacy policy
• Legal notice

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Incidence rates and temporal trends of cervical cancer relating to opportunistic screening in two developed metropolitan regions of Brazil: a population-based cohort study

Affiliations.

• 1 MD, PhD. Physician and Assistant Professor, Department of Obstetrics and Gynecology, School of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas (SP), Brazil.
• 2 MD, MSc. Physician and Doctoral Student, Lower Genital Tract Disease Service, Hospital Erasto Gaertner, Curitiba (PR), Brazil.
• 3 MSc. Statistician, Department of Statistics, Centro de Atenção Integral à Saúde da Mulher (CAISM), Universidade Estadual de Campinas (UNICAMP), Campinas (SP), Brazil.
• 4 MD, PhD. Physician and Professor, Department of Obstetrics and Gynecology, School of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas (SP), Brazil.
• 5 MD, PhD. Physician and Professor, Department of Obstetrics and Gynecology, School of Medical Sciences, Universidade Federal do Paraná (UFPR), Curitiba (PR), Brazil.
• PMID: 31691764
• PMCID: PMC9744015
• DOI: 10.1590/1516-3180.2018.0306220719

Background: Brazilian opportunistic screening programs for cervical cancer have limited impact. In the regions of two cities (Campinas and Curitiba) with high human development indices, consistent information from 96-97% of all cervical cancer cases managed within the public healthcare system is available.

Objective: To estimate the incidence rate (IR) and temporal trends in these regions, covering 2001-2012.

Design and setting: A population-based cohort study was conducted under the assumption that all cervical cancer cases were managed in cancer referral center hospitals.

Methods: 3,364 records (1,646 from Campinas; 1,718 from Curitiba) were analyzed to provide estimates of IR, age-standardized IR (ASR) and cervical cancer trends (shown per 100,000 women/year). Longitudinal patterns were analyzed using linear regression and shown as annual percentage change (APC); P < 0.05 for significance.

Results: Annual IR and ASR estimates for cervical cancer ranged from 3.8 to 8.0 over 2001-2012, decreasing over more recent years, and were similar for the two regions. The age-specific IR was about 50% lower among women aged 45 years or older (IR-2001/IR-2012: Campinas = 14.8/8.0; Curitiba = 18.7/8.3; P < 0.001). There was an increasing APC trend in Campinas among women aged 15-24 years, and a decreasing IR trend for squamous-cell histology in both regions (P < 0.05).

Conclusion: Cervical cancer incidence estimates showed slowly decreasing trends in both regions, most evidently for women aged 45 years or older and for squamous-cell histology. These findings reflect the opportunistic nature of the population screening program, despite the comparatively high economic development level in the two regions.

• Brazil / epidemiology
• Cohort Studies
• Early Detection of Cancer / statistics & numerical data*
• Mass Screening
• Middle Aged
• Spatio-Temporal Analysis
• Urban Population
• Uterine Cervical Neoplasms / diagnosis
• Uterine Cervical Neoplasms / epidemiology*
• Young Adult